|
|
 |
|
One Health News |
| |
|
| |
| Found 1196 Matching Results. View archived News Here. |
|
|
|
| HeadScratchers Season 2 Podcast with Dr. Gregory Gray [MD, MPH]: Coronavirus, Why Did it Catch Us Off Guard? - Duke Global Health (USA) - Friday, March 27, 2020 |
HeadScratchers Season 2 Podcast with Dr. Gregory Gray [MD, MPH]: Coronavirus, Why Did it Catch Us Off Guard? See: https://sites.globalhealth.duke.edu/dukeonehealth/media/podcasts/
Dr. Gray is a longstanding member of the One Health Initiative Advisory Board http://www.onehealthinitiative.com/advBoard.php and an Honorary Diplomate of the American Veterinary Epidemiology Society (AVES) https://www.avesociety.org/.
 |
|
| World One Health Congress Meeting postponed to October 30 -November 3 2020 - Thursday, March 26, 2020 |
|
|
The COVID-19 pandemic is rapidly escalating globally and putting an enormous strain on medical and other front-line health and community services everywhere. It seems very wrong and irresponsible for us to continue to plan on holding the Congress in Edinburgh in June, and potentially place you and all our delegates at risk of infection.
The #WOHC2020 Organising Committee has therefore decided to re-schedule the Congress, and now plans to hold it from 30 October to 3 November 2020 instead, ending most appropriately on the annual One Health Day.
The Congress will take place in the Edinburgh International Conference Centre (EICC), the same venue as initially planned. All registrations will be transferred to the new dates and all abstracts that have been accepted for presentation, planned side events and special sessions will remain in the programme. The early bird as well as the submission deadline for late breaker and COVID-19 abstracts have been extended to September 18.
We will continue to monitor the situation closely and provide further updates on our website. We hope you will all remain safe and well in the intervening period, and we look forward to welcoming you to an exciting and informative 6th World One Health Congress in October.
Stay safe!
|
|
|
John Mackenzie
Curtin University, Australia,
Co-founder One Health Platform Foundation,
Co-chair 6th World One Health Congress
|
|
Lisa Boden
University of Edinburgh, UK,
Co-chair 6th World One Health Congress
|
|
|
|
If I have already registered for WOHC 2020 in June and have paid my registration fee, will it be transferred to the new dates?
Yes, registration fees for WOHC and the fee for the Farewell dinner remain in place for the new Congress date.
Can I register for WOHC 2020 now?
Yes, registration for WOHC 2020 is open. Early bird registration closes on 18 September.
My abstract was accepted for oral/poster presentation. Will I still be able to present during the WOHC 2020 from 30 October to 3 November?
The rescheduled Congress from 30 October to 3 November is a fully equivalent replacement for the planned Congress, originally scheduled from 14-18 June, and all presentation confirmations remain the same.
I received information that my application for the Fellowship programme has been approved. Is it still valid for the WOHC from 30 October until 3 November?
Yes, your grant is transferred to the new dates.
Will the registration deadline for oral presentation authors be extended?
Yes, the new deadline is 4 September.
How will presentations be handled for authors for whom there is still a COVID-19 travel ban in October?
Every oral and poster presentation is required to have a registered author. So at least one author should register and pay the participation fee. Any author who is impacted by a travel ban, will be allowed to do a remote presentation. The exact process for remote oral and poster presentations will be announced in June 2020.
What is the refund policy if I have already paid the registration fee, but cannot attend the WOHC from 30 October till 3 November?
In case of cancellation before 19 September 2020, OHP will refund the applicant 50% of the registration fee. On or after 19 September 2020, no refund will be payable to the applicant.
I did not find an answer to my question above. Whom should I contact?
|
|
|
|
|
|
|
|
| New study explores the benefits of a One Health approach to investigating antimicrobial resistance - Tuesday, March 24, 2020 |
New study explores the benefits of a One Health approach to investigating antimicrobial resistance ...
In Vietnam, antimicrobial resistance in animal and human health settings poses a significant threat, but one that could be minimised by adopting a One ...
|
|
| Bats, Cats and Coronaviruses: What You Needto Know About COVID-19 (Livestream) FREE March 26, 2020 1:30 -2:30 P.M. - Monday, March 23, 2020 |
|
|
| Food & Agricultural Organization, World Organization for Animal Health, and World Health Organization in Asia and the Pacific: Uniting under ONE HEALTH to fight health risks at the human, animal and ecosystem interfaces - Sunday, March 22, 2020 |
Asia Pacific Tripartite
'One Health' seeks to design and implement programmes, policies, legislation and research in which multiple sectors communicate and coordinate to ...
The FAO, OIE and WHO in Asia and the Pacific (Asia Pacific Tripartite):
Uniting under ONE HEALTH to fight health risks at the human, animal and ecosystem interfaces
Contact us:
The Tripartite will provide technical support to countries to fight health risks at the human, animal and ecosystems interface. We will connect you with our relevant experts in the Asia Pacific Region.
E-mail: FAORAP-OneHealth@fao.org
|
|
| Centre for Applied One Health Research and Policy Advice (OHRP) - Saturday, March 21, 2020 |
OHRP
The Centre for Applied One Health Research and Policy Advice (OHRP) was established at the Jockey Club College of Veterinary Medicine and Life ...
|
|
| Q&A: The novel coronavirus outbreak causing COVID-19 - BMC Medicine - February 28, 2020 - Friday, March 20, 2020 |
Q&A: The novel coronavirus outbreak causing COVID-19
Fisher, D., Heymann, D. Q&A: The novel coronavirus outbreak causing COVID-19. BMC Med 18, 57 (2020). https://doi.org/10.1186/s12916-020-01533-w
SEE: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01533-w?utm_source=sn&utm_medium=referral&utm_content=null&utm_campaign=BSLB_4_CA01_GL_BSLB_USG_CA01_GL_LSGR_PubH_Coronavirus_LandingPage
Open Access Published: 28 February 2020
|
|
| COVID-19 and veterinary activities designated as essential - March 18, 2020 - Wednesday, March 18, 2020 |
COVID-19 and veterinary activities designated as essential
OIE/WVA Joint Statement https://www.oie.int/en/for-the-media/press-releases/detail/article/covid-19-and-veterinary-activities-designated-as-essential/
In the framework of the COVID-19 pandemic, the World Organisation for Animal Health (OIE) and the World Veterinary Association (WVA) jointly draw attention to the roles and responsibilities of the veterinary profession for public health. They highlight the specific veterinary activities which are key to ensure a continuum in food safety, disease prevention and emergency management.
Paris, 18 March 2020 - To effectively tackle the challenges posed by the COVID-19 pandemic, many governments around the world have taken restrictive measures to close non-essential businesses. These decisions raise questions regarding potential adaptations that need to be implemented by the veterinary profession.
In this context, the World Organisation for Animal Health (OIE) and the World Veterinary Association (WVA) advocate for the specific activities of Veterinary Services to be considered as essential businesses.
Maintaining the activities that are crucial to public health
Veterinarians are an integral part of the global health community. Beyond the activities linked to the health and welfare of animals, they have a key role in disease prevention and management, including those transmissible to humans, and to ensure food safety for the populations.
In the current situation, it is crucial that, amongst their numerous activities, they can sustain those necessary to ensure that:
- national and regional veterinary regulatory and inspection services can oversee the integrity of public health
- only healthy animals and their by-products enter the food supply to guarantee food safety for the populations,
- emergency situations can be addressed,
- preventative measures, such as vaccination against diseases with a significant public health or economic impact, are maintained.
- priority research activities continue.
Supporting veterinary activities in the current context
When conducting their work, veterinarians have the responsibility to safeguard their health, the health of those they work with, and their clients’ health. Hence, they must ensure that appropriate levels of biosecurity are implemented, that their personnel are protected with the necessary equipment, and that animal owners are informed of precautionary measures in place. It is the responsibility of each individual to ensure that appropriate behaviours are respected in the framework of these activities, to avoid further spread of COVID-19.
For more information:
|
|
| Symbios Technologies Announces Support for One Health concept/approach - March 15, 2020 - Sunday, March 15, 2020 |
Announces Support for One Health concept/approach
March 15, 2020
TO: One Health Initiative team
Please add Symbios Technologies, Inc. to your supporters list. Here is background on the company/technology and potential applications to animal, human, and ecosystem health:
- Prototype-stage low-carbon footprint aqueous plasma platform the Symbios Tubular Plasma Reactor (TPR) for water treatment (both disinfection and carcinogen destruction) and discovery/characterization-stage bioactive chemistry generation including Aqueous Plasma Chemotherapeutics (APC) for cancer and infectious disease prevention/treatment.
- In partnership with the Colorado State University Flint Animal Cancer Center and its Director of Clinical Research Dr. Doug Thamm, Symbios completed an NCI Phase I SBIR demonstrating in vitro efficacy of APC for pancreatic cancer and some characterization/MOA work, with Phase II pending.
- We have 2 issued/allowed patents, one for the TPR and one for TPR-generated APC for pancreatic cancer, and have published peer-reviewed articles, one a literature review published in Plasma Medicine journal (Begell House), PMCID PMC5394942, “Aqueous Plasma Pharmacy: Preparation Methods, Chemistry, and Therapeutic Applications” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394942/, and the other a paper on use of our plasma reactor in place of chlorine or other chemicals to treat power plant cooling tower water for Legionella and corrosion-causing bacteria, “An innovative non-thermal plasma reactor to eliminate microorganisms in water” (Desalination & Water Treatment, Taylor & Francis).
- We have a licensing partnership to develop and commercialize combination therapies for multiple indications possibly to include COVID-19 and other viral infections, canine mammary and other cancers in animals, and pancreatic, NSCLC, and other cancers in humans.
- We have been exploring what we call the “biosphere health nexus” synergies similar to those the One Health Initiative contemplates, and many problems in addition to the ones discussed above that the TPR and APC and other plasma/electrochemical technologies can help solve. I’d be happy to review a slide presenting these synergies and opportunities with anyone interested.
- Looking for partners and collaborators.
I hope to stay in touch and support your efforts moving forward.
Best regards,
Justin Bzdek, President & CEO
Symbios Technologies, Inc., P.O. Box 273261
Fort Collins, CO 80527
justin@symbiostechnologies.com
www.SymbiosPlasma.com
|
|
| RE: COVID-19 (Coronavirus)...a simple idea to increase number of hospital beds/ventilators etc. for Emergency situation(s) - Friday, March 13, 2020 |
March 12, 2020
RE: COVID-19 (Coronavirus)...a simple idea to increase number of hospital beds/ventilators etc. for Emergency situation(s)
Contact: *CRAIG N. CARTER, DVM MS PhD Dipl. ACVPM DSNAP
Director & Professor, Epidemiology
Veterinary Diagnostic Laboratory
Department of Veterinary Science
College of Agriculture, Food & the Environment
College of Public Health
University of Kentucky
1490 Bull Lea Rd.
Lexington, KY 40511
craig.carter@uky.edu
859-257-8283 (Office)
859-321-4800 (Business cell)
859-255-1624 (Fax)
I just listened to a piece on NBC on Sirius XM that spoke to a predicted shortage of hospital beds/respirators in the US in face of the coronavirus outbreak. I believe they quoted only 25,000 beds/ventilators in US facilities with a projected need of 100,000 or more.
What no one seems to be considering is that the US military and Homeland Security have thousands of mobile field hospitals that can be deployed strategically around the U.S. on a moment’s notice by the President. If deployed now, these hospitals could be in place and fully functional within weeks, significantly increasing the number of treatment facilities, doctors, nurses and technicians that could easily manage patients with serious respiratory disease or any other condition. My unit helped to establish the first base in Afghanistan after 9-11 which included a large field hospital to treat combatants with severe wounds and injuries of all kinds. This was done in very short order and could easily be done right here in CONUS. Further, this would be win-win as our active duty and reserve medical corps troops need and would welcome this real-life field training experience. I think this option should be seriously considered given the fact that we are still ahead of the predicted exponential increase in new clinical cases of coronavirus infections over the next few weeks. If we begin today, we could have hundreds of additional hospitals established within that timeframe. Of course, the USAF is fully ready to provide expert, fast patient and supply transport as needed. They train for this and always welcome the opportunity for the real deal in the field.
*Note: Dr. Carter is a Retired COL, U.S. Army Reserve; President, American Veterinary Epidemiology Society (AVES) and a member of the One Health Initiative team.
One Health Initiative Autonomous pro bono Team:
Laura H. Kahn, MD, MPH, MPP ▪ Bruce Kaplan, DVM ▪ Thomas P. Monath, MD ▪ Lisa A. Conti, DVM, MPH ▪ Thomas M. Yuill, PhD ▪ Helena J. Chapman, MD, MPH, PhD ▪ Craig N. Carter, DVM, PhD
|
|
|
|
|
|
|
